$HR
Healthcare Realty Trust Inc Stock $hr

$hr Overview Financials Valuation SEC Filings Company Website

2017 Q1 Form 10-Q Financial Statement

#000136060417000035 Filed on April 27, 2017

Income Statement

Concept	2017 Q1	2016 Q1
Revenue	$124.3M	$107.3M
YoY Change	15.87%	8.93%
Cost Of Revenue	$37.90M	$35.40M
YoY Change	7.06%	3.21%
Gross Profit	$66.80M	$64.60M
YoY Change	3.41%	3.86%
Gross Profit Margin	53.72%	60.2%
Selling, General & Admin	$8.800M	$10.20M
YoY Change	-13.73%	56.92%
% of Gross Profit	13.17%	15.79%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$34.50M	$31.20M
YoY Change	10.58%	3.31%
% of Gross Profit	51.65%	48.3%
Operating Expenses	$43.20M	$40.60M
YoY Change	6.4%	14.04%
Operating Profit	$29.56M	$27.55M
YoY Change	7.32%	18.25%
Interest Expense	-$14.20M	-$14.90M
YoY Change	-4.7%	-18.13%
% of Operating Profit	-48.03%	-54.09%
Other Income/Expense, Net	$8.000K	$53.00K
YoY Change	-84.91%	253.33%
Pretax Income	$31.80M	$9.200M
YoY Change	245.65%	84.0%
Income Tax
% Of Pretax Income
Net Earnings	$13.55M	$9.860M
YoY Change	37.37%	44.91%
Net Earnings / Revenue	10.89%	9.19%
Basic Earnings Per Share	$0.10	$0.08
Diluted Earnings Per Share	$0.09	$0.08
COMMON SHARES
Basic Shares Outstanding	141.8M shares	129.3M shares
Diluted Shares Outstanding	146.1M shares	131.2M shares

Balance Sheet

Concept	2017 Q1	2016 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.500M	$2.200M
YoY Change	-31.82%	-78.85%
Cash & Equivalents	$16.03M	$13.83M
Short-Term Investments
Other Short-Term Assets	$59.00M	$34.00M
YoY Change	73.53%	30.77%
Inventory
Prepaid Expenses
Receivables	$9.000M	$8.000M
Other Receivables	$85.00M	$78.00M
Total Short-Term Assets	$1.500M	$2.200M
YoY Change	-31.82%	-78.85%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.726B	$2.651B
YoY Change	2.81%	3.0%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$120.0M	$700.0K
YoY Change	17042.86%	-95.07%
Total Long-Term Assets	$3.752B	$3.308B
YoY Change	13.4%	8.87%
TOTAL ASSETS
Total Short-Term Assets	$1.500M	$2.200M
Total Long-Term Assets	$3.752B	$3.308B
Total Assets	$3.753B	$3.311B
YoY Change	13.37%	8.57%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.70M	$66.00M
YoY Change	-5.0%	31.74%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$62.70M	$66.00M
YoY Change	-5.0%	31.74%
LONG-TERM LIABILITIES
Long-Term Debt	$1.279B	$1.418B
YoY Change	-9.84%	-1.82%
Other Long-Term Liabilities	$44.50M	$64.30M
YoY Change	-30.79%	-0.46%
Total Long-Term Liabilities	$1.323B	$1.483B
YoY Change	-10.75%	-1.76%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.70M	$66.00M
Total Long-Term Liabilities	$1.323B	$1.483B
Total Liabilities	$1.999B	$1.837B
YoY Change	8.79%	14.94%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock	$2.756B	$2.423B
YoY Change	13.71%	6.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$1.657B	$1.444B
YoY Change
Total Liabilities & Shareholders Equity	$3.753B	$3.311B
YoY Change	13.37%	8.57%

Cashflow Statement

Concept	2017 Q1	2016 Q1
OPERATING ACTIVITIES
Net Income	$13.55M	$9.860M
YoY Change	37.37%	44.91%
Depreciation, Depletion And Amortization	$34.50M	$31.20M
YoY Change	10.58%	3.31%
Cash From Operating Activities	$47.01M	$40.45M
YoY Change	16.22%	8.76%
INVESTING ACTIVITIES
Capital Expenditures	-$33.10M	-$48.80M
YoY Change	-32.17%	1.04%
Acquisitions
YoY Change
Other Investing Activities	$76.90M	-$8.000M
YoY Change	-1061.25%	86.05%
Cash From Investing Activities	-$42.85M	-$168.3M
YoY Change	-74.54%	299.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$3.118M	-$89.86M
YoY Change	-103.47%	-7054.8%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-$5.127M	$128.6M
YoY Change	-103.99%	1496.9%
NET CHANGE
Cash From Operating Activities	$47.01M	$40.45M
Cash From Investing Activities	-$42.85M	-$168.3M
Cash From Financing Activities	-$5.127M	$128.6M
Net Change In Cash	-$968.0K	$757.0K
YoY Change	-227.87%	-75.61%
FREE CASH FLOW
Cash From Operating Activities	$47.01M	$40.45M
Capital Expenditures	-$33.10M	-$48.80M
Free Cash Flow	$80.11M	$89.25M
YoY Change	-10.24%	4.39%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2017Q1	dei	Amendment Flag AmendmentFlag	false
CY2017Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	15919000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed In Place Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedInPlaceLeases	3185000	USD
CY2016Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	1813000	USD
CY2017Q1	hta	Acquisition Related Expenses AcquisitionRelatedExpenses	284000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	65000	USD
CY2017Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2017Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2017
CY2017Q1	dei	Document Period End Date DocumentPeriodEndDate	2017-03-31
CY2017Q1	dei	Document Type DocumentType	10-Q
CY2017Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001360604
CY2017Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	143841711	shares
CY2017Q1	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2017Q1	dei	Entity Registrant Name EntityRegistrantName	HEALTHCARE TRUST OF AMERICA, INC.
CY2016Q1	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P8Y10M24D
CY2017Q1	hta	Acquired Finite Lived Intangible Liabilities Weighted Average Useful Life AcquiredFiniteLivedIntangibleLiabilitiesWeightedAverageUsefulLife	P10Y2M12D
CY2017Q1	hta	Aggregate Gross Sales Priceof Disposed Properties AggregateGrossSalesPriceofDisposedProperties	5000000	USD
CY2017Q1	hta	Area Of Real Estate Properties Sold AreaOfRealEstatePropertiesSold	48000	sqft
CY2017Q1	hta	Asset Acquisition Transaction Costs Capitalized AssetAcquisitionTransactionCostsCapitalized	300000	USD
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leasehold Interests BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeaseholdInterests	50000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leasehold Interests BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeaseholdInterests	0	USD
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	840000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Above Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedAboveMarketLeases	0	USD
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leasehold Interests BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeaseholdInterests	1099000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leasehold Interests BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeaseholdInterests	0	USD
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Below Market Leases BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedBelowMarketLeases	5382000	USD
CY2016Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	3321000	USD
CY2017Q1	hta	Business Combination Recognized Identifiable Assets Acquiredand Liabilities Assumed Other Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredandLiabilitiesAssumedOtherNet	1230000	USD
CY2016Q1	hta	Contractual Purchase Priceto Acquire Businesses ContractualPurchasePricetoAcquireBusinesses	162007000	USD
CY2017Q1	hta	Contractual Purchase Priceto Acquire Businesses ContractualPurchasePricetoAcquireBusinesses	39000000	USD
CY2017Q1	hta	Contractual Purchase Priceto Acquire Businesses ContractualPurchasePricetoAcquireBusinesses	39046000	USD
CY2017Q1	hta	Deferred Finance Costs Amortization Expense After Year Five DeferredFinanceCostsAmortizationExpenseAfterYearFive	1727000	USD
CY2017Q1	hta	Deferred Finance Costs Amortization Expense Year Five DeferredFinanceCostsAmortizationExpenseYearFive	1060000	USD
CY2017Q1	hta	Deferred Finance Costs Amortization Expense Year Four DeferredFinanceCostsAmortizationExpenseYearFour	1338000	USD
CY2017Q1	hta	Deferred Finance Costs Amortization Expense Year Three DeferredFinanceCostsAmortizationExpenseYearThree	1780000	USD
CY2017Q1	hta	Deferred Finance Costs Amortization Expense Year Two DeferredFinanceCostsAmortizationExpenseYearTwo	1775000	USD
CY2017Q1	hta	Deferred Finance Costs Future Amortization Expense Remainder Of Fiscal Year DeferredFinanceCostsFutureAmortizationExpenseRemainderOfFiscalYear	1362000	USD
CY2016Q4	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	4198000	USD
CY2017Q1	hta	Deferred Financing Costs Net DeferredFinancingCostsNet	3867000	USD
CY2016Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	37091000	USD
CY2017Q1	hta	Depreciation Amortizationand Other DepreciationAmortizationandOther	46213000	USD
CY2016Q4	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	8946000	USD
CY2017Q1	hta	Finite Lived Intangible Liabilities Accumulated Amortization FiniteLivedIntangibleLiabilitiesAccumulatedAmortization	9704000	USD
CY2016Q4	hta	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	46002000	USD
CY2017Q1	hta	Finite Lived Intangible Liabilities Gross FiniteLivedIntangibleLiabilitiesGross	45713000	USD
CY2016Q4	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	37056000	USD
CY2017Q1	hta	Finite Lived Intangible Liabilities Net FiniteLivedIntangibleLiabilitiesNet	36009000	USD
CY2016	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P28Y6M
CY2017Q1	hta	Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments	-515000	USD
CY2016Q4	us-gaap	Accounts Receivable Net AccountsReceivableNet	8722000	USD
CY2017Q1	hta	Maximum State Concentration In Portfolio By Gross Leasable Area MaximumStateConcentrationInPortfolioByGrossLeasableArea	0.13
CY2016Q1	hta	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Note Receivable Transferred NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationNoteReceivableTransferred	0	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	10036000	USD
CY2017Q1	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	98222000	USD
CY2017Q1	hta	Finite Lived Intangible Liabilities Weighted Average Remaining Life FiniteLivedIntangibleLiabilitiesWeightedAverageRemainingLife	P29Y
CY2017Q1	hta	Gross Leasable Area In Portfolio GrossLeasableAreaInPortfolio	17800000	sqft
CY2017Q1	hta	Inceptionto Date Acquisition Purchase Price InceptiontoDateAcquisitionPurchasePrice	4300000000	USD
CY2016Q1	hta	Increase Decreasein Restricted Cash Escrow Depositsand Other IncreaseDecreaseinRestrictedCashEscrowDepositsandOther	799000	USD
CY2017Q1	hta	Increase Decreasein Restricted Cash Escrow Depositsand Other IncreaseDecreaseinRestrictedCashEscrowDepositsandOther	-5771000	USD
CY2016Q1	hta	Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities	446000	USD
CY2017Q1	hta	Increase Decreasein Security Deposits Prepaid Rentand Other Liabilities IncreaseDecreaseinSecurityDepositsPrepaidRentandOtherLiabilities	682000	USD
CY2016Q1	hta	Interest Expense Derivative Financial Instruments InterestExpenseDerivativeFinancialInstruments	645000	USD
CY2017Q1	hta	Interest Expense Derivative Financial Instruments InterestExpenseDerivativeFinancialInstruments	324000	USD
CY2016Q1	hta	Interest Expense Related To Derivative Financial Instruments And Net Change Fair Value Of Derivative Financial Instruments InterestExpenseRelatedToDerivativeFinancialInstrumentsAndNetChangeFairValueOfDerivativeFinancialInstruments	3437000	USD
CY2017Q1	hta	Noncash Or Part Noncash Acquisition Noncash Financial Or Equity Instrument Consideration Note Receivable Transferred NoncashOrPartNoncashAcquisitionNoncashFinancialOrEquityInstrumentConsiderationNoteReceivableTransferred	2494000	USD
CY2017Q1	hta	Noncontrolling Interest Increasefrom Acquisition NoncontrollingInterestIncreasefromAcquisition	610000	USD
CY2016Q1	hta	Noncontrolling Interestand Other Redeemed During Period Value NoncontrollingInterestandOtherRedeemedDuringPeriodValue	0	USD
CY2017Q1	hta	Percentage Of Gross Leasable Area Located In Top75 Metropolitan Statistical Areas PercentageOfGrossLeasableAreaLocatedInTop75MetropolitanStatisticalAreas	0.92
CY2017Q1	hta	Percentage Of Gross Leasable Area Oncampus Aligned PercentageOfGrossLeasableAreaOncampusAligned	0.96
CY2016Q1	hta	Proceedsfrom Paymentsof Security Deposits ProceedsfromPaymentsofSecurityDeposits	729000	USD
CY2017Q1	hta	Proceedsfrom Paymentsof Security Deposits ProceedsfromPaymentsofSecurityDeposits	14000	USD
CY2016Q4	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	173461000	USD
CY2017Q1	hta	Receivables And Other Assets Net ReceivablesAndOtherAssetsNet	179719000	USD
CY2016Q4	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	49859000	USD
CY2017Q1	hta	Security Deposit Liability Advance Rentand Other Liabilities SecurityDepositLiabilityAdvanceRentandOtherLiabilities	51409000	USD
CY2016Q4	us-gaap	Accounts Payable And Accrued Liabilities Current And Noncurrent AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent	105034000	USD
CY2017Q1	us-gaap	Accounts Receivable Net AccountsReceivableNet	8750000	USD
CY2016Q4	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1068961000	USD
CY2017Q1	us-gaap	Accumulated Distributions In Excess Of Net Income AccumulatedDistributionsInExcessOfNetIncome	1098561000	USD
CY2016Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-85000	USD
CY2016Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P10Y6M
CY2017Q1	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P11Y3M18D
CY2016Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2754818000	USD
CY2017Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	2754229000	USD
CY2016Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	1803000	USD
CY2017Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2530000	USD
CY2016Q1	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	1052000	USD
CY2017Q1	us-gaap	Amortization Of Deferred Leasing Fees AmortizationOfDeferredLeasingFees	1262000	USD
CY2016Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	331000	USD
CY2017Q1	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	331000	USD
CY2016Q4	us-gaap	Assets Assets	3747844000	USD
CY2017Q1	us-gaap	Assets Assets	3753017000	USD
CY2016Q4	us-gaap	Assets Fair Value Disclosure Nonrecurring AssetsFairValueDisclosureNonrecurring	8191000	USD
CY2017Q1	us-gaap	Assets Fair Value Disclosure Nonrecurring AssetsFairValueDisclosureNonrecurring	0	USD
CY2017Q1	us-gaap	Assets Needed For Immediate Settlement Aggregate Fair Value AssetsNeededForImmediateSettlementAggregateFairValue	1800000	USD
CY2016Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	128945000	USD
CY2017Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	29762000	USD
CY2016Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	17315000	USD
CY2017Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	4934000	USD
CY2016Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	158686000	USD
CY2017Q1	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedNet	37816000	USD
CY2016Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5688000	USD
CY2017Q1	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	5696000	USD
CY2015Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13070000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13827000	USD
CY2016Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	11231000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	16034000	USD
CY2016Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	757000	USD
CY2017Q1	us-gaap	Cash And Cash Equivalents Period Increase Decrease CashAndCashEquivalentsPeriodIncreaseDecrease	4803000	USD
CY2017Q1	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	700000	USD
CY2016Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2017Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2016Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.295
CY2017Q1	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.300
CY2016Q4	us-gaap	Common Stock Value CommonStockValue	1417000	USD
CY2017Q1	us-gaap	Common Stock Value CommonStockValue	1418000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	9891000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	13490000	USD
CY2016Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	145000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	422000	USD
CY2017Q1	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	13912000	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Securities DerivativeCollateralObligationToReturnSecurities	0	USD
CY2016Q1	us-gaap	Costs And Expenses CostsAndExpenses	79767000	USD
CY2017Q1	us-gaap	Costs And Expenses CostsAndExpenses	94783000	USD
CY2016Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1781466000	USD
CY2017Q1	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1823312000	USD
CY2016Q4	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3034000	USD
CY2017Q1	us-gaap	Debt Instrument Unamortized Discount Premium Net DebtInstrumentUnamortizedDiscountPremiumNet	3062000	USD
CY2016Q4	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	20811000	USD
CY2017Q1	us-gaap	Deferred Costs Leasing Net DeferredCostsLeasingNet	21906000	USD
CY2016Q4	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9527000	USD
CY2017Q1	us-gaap	Deferred Finance Costs Net DeferredFinanceCostsNet	9042000	USD
CY2016Q4	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	74052000	USD
CY2017Q1	us-gaap	Deferred Rent Receivables Net DeferredRentReceivablesNet	76287000	USD
CY2016Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	37828000	USD
CY2017Q1	us-gaap	Depreciation And Amortization DepreciationAndAmortization	47056000	USD
CY2016Q4	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2017Q1	us-gaap	Derivative Asset Fair Value Gross Liability DerivativeAssetFairValueGrossLiability	0	USD
CY2016Q4	us-gaap	Derivative Assets DerivativeAssets	541000	USD
CY2017Q1	us-gaap	Derivative Assets DerivativeAssets	1034000	USD
CY2016Q4	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2017Q1	us-gaap	Derivative Collateral Obligation To Return Cash DerivativeCollateralObligationToReturnCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Cash DerivativeCollateralRightToReclaimCash	0	USD
CY2016Q4	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2017Q1	us-gaap	Derivative Collateral Right To Reclaim Securities DerivativeCollateralRightToReclaimSecurities	0	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	541000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset DerivativeFairValueOfDerivativeAsset	1034000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	541000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Asset Amount Offset Against Collateral DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral	1034000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1920000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability DerivativeFairValueOfDerivativeLiability	1653000	USD
CY2016Q4	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1920000	USD
CY2017Q1	us-gaap	Derivative Fair Value Of Derivative Liability Amount Not Offset Against Collateral DerivativeFairValueOfDerivativeLiabilityAmountNotOffsetAgainstCollateral	1653000	USD
CY2016Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	1920000	USD
CY2017Q1	us-gaap	Derivative Liabilities DerivativeLiabilities	1653000	USD
CY2016Q4	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2017Q1	us-gaap	Derivative Liability Fair Value Gross Asset DerivativeLiabilityFairValueGrossAsset	0	USD
CY2017Q1	us-gaap	Derivative Net Liability Position Aggregate Fair Value DerivativeNetLiabilityPositionAggregateFairValue	1800000	USD
CY2016Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	33353000	USD
CY2017Q1	us-gaap	Direct Costs Of Leased And Rented Property Or Equipment DirectCostsOfLeasedAndRentedPropertyOrEquipment	39020000	USD
CY2016Q1	us-gaap	Dividends Dividends	39083000	USD
CY2017Q1	us-gaap	Dividends Dividends	44466000	USD
CY2016Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	38784000	USD
CY2017Q1	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	44489000	USD
CY2016Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.08
CY2017Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.10
CY2016Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.08
CY2017Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.09
CY2016Q4	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	256305000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	266758000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	534108000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	533844000	USD
CY2016Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	277803000	USD
CY2017Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	267086000	USD
CY2016	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P16Y1M6D
CY2017Q1	us-gaap	Finite Lived Intangible Assets Remaining Amortization Period1 FiniteLivedIntangibleAssetsRemainingAmortizationPeriod1	P16Y4M24D
CY2017Q1	us-gaap	Gain Loss On Cash Flow Hedge Ineffectiveness Net GainLossOnCashFlowHedgeIneffectivenessNet	6000	USD
CY2016Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	-2792000	USD
CY2017Q1	us-gaap	Gain Loss On Interest Rate Derivative Instruments Not Designated As Hedging Instruments GainLossOnInterestRateDerivativeInstrumentsNotDesignatedAsHedgingInstruments	839000	USD
CY2016Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	0	USD
CY2017Q1	us-gaap	Gain Loss On Sale Of Properties GainLossOnSaleOfProperties	3000	USD
CY2016Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	0	USD
CY2017Q1	us-gaap	Gains Losses On Extinguishment Of Debt GainsLossesOnExtinguishmentOfDebt	-32000	USD
CY2016Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	6773000	USD
CY2017Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8423000	USD
CY2016Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	88000	USD
CY2017Q1	us-gaap	Income Taxes Paid IncomeTaxesPaid	60000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-10370000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-7934000	USD
CY2016Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	1438000	USD
CY2017Q1	us-gaap	Increase Decrease In Accounts Receivable And Other Operating Assets IncreaseDecreaseInAccountsReceivableAndOtherOperatingAssets	7771000	USD
CY2016Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	14128000	USD
CY2017Q1	us-gaap	Interest Expense Debt InterestExpenseDebt	16058000	USD
CY2016Q1	us-gaap	Interest Income Operating InterestIncomeOperating	65000	USD
CY2017Q1	us-gaap	Interest Income Operating InterestIncomeOperating	354000	USD
CY2016Q1	us-gaap	Interest Paid InterestPaid	13062000	USD
CY2017Q1	us-gaap	Interest Paid InterestPaid	19186000	USD
CY2016Q4	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	3466516000	USD
CY2017Q1	us-gaap	Investment Building And Building Improvements InvestmentBuildingAndBuildingImprovements	3500633000	USD
CY2016Q4	us-gaap	Land Land	386526000	USD
CY2017Q1	us-gaap	Land Land	392714000	USD
CY2016Q4	us-gaap	Liabilities Liabilities	1962774000	USD
CY2017Q1	us-gaap	Liabilities Liabilities	1998501000	USD
CY2016Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3747844000	USD
CY2017Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	3753017000	USD
CY2017Q1	us-gaap	Limited Liability Company Llc Or Limited Partnership Lp Managing Member Or General Partner Ownership Interest LimitedLiabilityCompanyLLCOrLimitedPartnershipLPManagingMemberOrGeneralPartnerOwnershipInterest	0.970
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	1768900000	USD
CY2016Q4	us-gaap	Long Term Debt LongTermDebt	1768905000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	1811208000	USD
CY2017Q1	us-gaap	Long Term Debt LongTermDebt	1811200000	USD
CY2016Q4	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1784000000	USD
CY2017Q1	us-gaap	Long Term Debt Fair Value LongTermDebtFairValue	1831700000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal After Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive	947687000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Five LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive	303842000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	219795000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	310839000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	4721000	USD
CY2017Q1	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	36428000	USD
CY2016Q4	us-gaap	Minority Interest MinorityInterest	93143000	USD
CY2017Q1	us-gaap	Minority Interest MinorityInterest	92854000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	128614000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-5127000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-168309000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-37083000	USD
CY2016Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	40452000	USD
CY2017Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	47013000	USD
CY2016Q1	us-gaap	Net Income Loss NetIncomeLoss	9860000	USD
CY2017Q1	us-gaap	Net Income Loss NetIncomeLoss	13545000	USD
CY2016Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	176000	USD
CY2017Q1	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	455000	USD
CY2016Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	10005000	USD
CY2017Q1	us-gaap	Net Income Loss Including Portion Attributable To Nonredeemable Noncontrolling Interest NetIncomeLossIncludingPortionAttributableToNonredeemableNoncontrollingInterest	13970000	USD
CY2016Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	53000	USD
CY2017Q1	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	8000	USD
CY2017Q1	us-gaap	Number Of States In Which Entity Operates NumberOfStatesInWhichEntityOperates	31	States
CY2016Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	27548000	USD
CY2017Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	29564000	USD
CY2016Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	107250000	USD
CY2017Q1	us-gaap	Operating Leases Income Statement Lease Revenue OperatingLeasesIncomeStatementLeaseRevenue	123993000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-88000	USD
CY2016Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	0	USD
CY2017Q1	us-gaap	Other Comprehensive Income Unrealized Gain Loss On Derivatives Arising During Period Net Of Tax OtherComprehensiveIncomeUnrealizedGainLossOnDerivativesArisingDuringPeriodNetOfTax	-88000	USD
CY2016Q4	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	467571000	USD
CY2017Q1	us-gaap	Other Finite Lived Intangible Assets Gross OtherFiniteLivedIntangibleAssetsGross	467559000	USD
CY2016Q4	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	46318000	USD
CY2017Q1	us-gaap	Other Intangible Assets Net OtherIntangibleAssetsNet	45301000	USD
CY2016Q4	us-gaap	Other Receivables OtherReceivables	9233000	USD
CY2017Q1	us-gaap	Other Receivables OtherReceivables	8949000	USD
CY2016Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	1901000	USD
CY2017Q1	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	3118000	USD
CY2016Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	37473000	USD
CY2017Q1	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	42536000	USD
CY2016Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	737000	USD
CY2017Q1	us-gaap	Payments Of Dividends Minority Interest PaymentsOfDividendsMinorityInterest	1332000	USD
CY2016Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	8824000	USD
CY2017Q1	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	12894000	USD
CY2016Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	158686000	USD
CY2017Q1	us-gaap	Payments To Acquire Real Estate PaymentsToAcquireRealEstate	34706000	USD
CY2016Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2017Q1	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.01
CY2016Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2017Q1	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	200000000	shares
CY2016Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2016Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2017Q1	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2016Q4	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2017Q1	us-gaap	Preferred Stock Value PreferredStockValue	0	USD
CY2016Q4	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	55904000	USD
CY2017Q1	us-gaap	Prepaid Expense And Other Assets PrepaidExpenseAndOtherAssets	58926000	USD
CY2016Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	91757000	USD
CY2017Q1	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2016Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	166000000	USD
CY2017Q1	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	92000000	USD
CY2016Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	0	USD
CY2017Q1	us-gaap	Proceeds From Sale Of Real Estate ProceedsFromSaleOfRealEstate	4746000	USD
CY2016Q1	us-gaap	Profit Loss ProfitLoss	10036000	USD
CY2017Q1	us-gaap	Profit Loss ProfitLoss	14000000	USD
CY2016Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	92000	USD
CY2017Q1	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	103000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	817593000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	856986000	USD
CY2016Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4320613000	USD
CY2017Q1	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	4360906000	USD
CY2016Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3503020000	USD
CY2017Q1	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	3503920000	USD
CY2016Q4	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	4653000	USD
CY2017Q1	us-gaap	Redeemable Noncontrolling Interest Equity Carrying Amount RedeemableNoncontrollingInterestEquityCarryingAmount	4661000	USD
CY2016Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	88000000	USD
CY2017Q1	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	10000000	USD
CY2016Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	1761000	USD
CY2017Q1	us-gaap	Repayments Of Secured Debt RepaymentsOfSecuredDebt	40155000	USD
CY2016Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	13814000	USD
CY2017Q1	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	8043000	USD
CY2016Q1	us-gaap	Revenues Revenues	107315000	USD
CY2017Q1	us-gaap	Revenues Revenues	124347000	USD
CY2016Q1	us-gaap	Share Based Compensation ShareBasedCompensation	1803000	USD
CY2017Q1	us-gaap	Share Based Compensation ShareBasedCompensation	2530000	USD
CY2016Q1	us-gaap	Stock Issued1 StockIssued1	0	USD
CY2017Q1	us-gaap	Stock Issued1 StockIssued1	610000	USD
CY2016Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	91269000	USD
CY2016Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	1901000	USD
CY2017Q1	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	3118000	USD
CY2016Q4	us-gaap	Stockholders Equity StockholdersEquity	1687274000	USD
CY2017Q1	us-gaap	Stockholders Equity StockholdersEquity	1657001000	USD
CY2015Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1406958000	USD
CY2016Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1469051000	USD
CY2016Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1780417000	USD
CY2017Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1749855000	USD
CY2016Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	131240000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	146117000	shares
CY2016Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	129336000	shares
CY2017Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	141780000	shares
CY2017Q1	us-gaap	Nature Of Operations NatureOfOperations	<div style="font-family:Times New Roman;font-size:10pt;"><div style="line-height:120%;padding-top:13px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Organization and Description of Business </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HTA, a Maryland corporation, and </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, a Delaware limited partnership, were incorporated or formed, as applicable, on </font><font style="font-family:inherit;font-size:10pt;color:#000000;text-decoration:none;">April 20, 2006</font><font style="font-family:inherit;font-size:10pt;">. HTA operates as a REIT and is the general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, which is the operating partnership. As of </font><font style="font-family:Times New Roman;font-size:10pt;color:#000000;text-decoration:none;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, HTA owned a </font><font style="font-family:inherit;font-size:10pt;">97.0%</font><font style="font-family:inherit;font-size:10pt;"> partnership interest and other limited partners, including some of HTA’s directors, executive officers and their affiliates, owned the remaining partnership interest (including the LTIP Units) in </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. As the sole general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, HTA has the full, exclusive and complete responsibility for </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">’s day-to-day management and control. HTA operates in an umbrella partnership REIT structure in which </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;"> and its subsidiaries hold substantially all of the assets. HTA’s only material asset is its ownership of partnership interests of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. As a result, HTA does not conduct business itself, other than acting as the sole general partner of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">, issuing public equity from time to time and guaranteeing certain debts of </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;">. </font><font style="font-family:inherit;font-size:10pt;">HTALP</font><font style="font-family:inherit;font-size:10pt;"> conducts the operations of the business and issues publicly-traded debt, but has no publicly-traded equity. </font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:29px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">HTA is one of the largest publicly-traded REITs focused on medical office buildings (“MOBs”) in the U.S. as measured by the gross leasable area (“GLA”) of its MOBs. HTA conducts substantially all of its operations through HTALP. We invest in MOBs that we believe will serve the future of healthcare delivery, and MOBs that are primarily located on health system campuses, near university medical centers, or in core community outpatient locations. We also focus on our key markets that have certain demographic and macro-economic trends and where we can utilize our institutional property management and leasing platform to generate strong tenant relationships and operating cost efficiencies. Our primary objective is to maximize stockholder value with disciplined growth through strategic investments that provide an attractive risk-adjusted return for our stockholders by consistently increasing our cash flow. In pursuing this objective, we: (i) seek internal growth through proactive asset management, leasing and property management oversight; (ii) target accretive acquisitions of MOBs in markets with attractive demographics that complement our existing portfolio; and (iii) actively manage our balance sheet to maintain flexibility with conservative leverage.  Additionally, from time to time we consider, on an opportunistic basis, significant portfolio acquisitions that we believe fit our core business and could enhance our existing portfolio. HTA has qualified to be taxed as a REIT for federal income tax purposes and intends to continue to be taxed as a REIT.</font></div><div style="line-height:120%;padding-top:6px;text-align:left;text-indent:30px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Since 2006, we have invested </font><font style="font-family:inherit;font-size:10pt;">$4.3 billion</font><font style="font-family:inherit;font-size:10pt;"> to create a portfolio of MOBs and other healthcare assets consisting of approximately </font><font style="font-family:inherit;font-size:10pt;">17.8 million</font><font style="font-family:inherit;font-size:10pt;"> square feet of GLA throughout the U.S. As of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">, approximately </font><font style="font-family:inherit;font-size:10pt;">96%</font><font style="font-family:inherit;font-size:10pt;"> of our portfolio, based on GLA, was located on the campuses of, or aligned with, nationally or regionally recognized healthcare systems. Our portfolio is diversified geographically across </font><font style="font-family:inherit;font-size:10pt;">31</font><font style="font-family:inherit;font-size:10pt;"> states, with no state having more than </font><font style="font-family:inherit;font-size:10pt;">13%</font><font style="font-family:inherit;font-size:10pt;"> of our total GLA as of </font><font style="font-family:inherit;font-size:10pt;">March 31, 2017</font><font style="font-family:inherit;font-size:10pt;">. We are concentrated in </font><font style="font-family:inherit;font-size:10pt;">15</font><font style="font-family:inherit;font-size:10pt;"> to </font><font style="font-family:inherit;font-size:10pt;">20</font><font style="font-family:inherit;font-size:10pt;"> key markets that are experiencing higher economic and demographic trends than other markets, on average, that we expect will drive demand for MOBs. Approximately </font><font style="font-family:inherit;font-size:10pt;">92%</font><font style="font-family:inherit;font-size:10pt;"> of our portfolio, based on GLA, is located in the top </font><font style="font-family:inherit;font-size:10pt;">75</font><font style="font-family:inherit;font-size:10pt;"> metropolitan statistical areas (“MSAs”) with Boston, Hartford/New Haven, Dallas, Houston, Phoenix and Orange County/Los Angeles being our largest markets by investment. </font></div><div style="line-height:120%;padding-top:6px;text-indent:32px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Our principal executive office is located at 16435 North Scottsdale Road, Suite 320, Scottsdale, Arizona, 85254.</font></div></div>

Files In Submission

Name	View Source	Status
0001360604-17-000035-index-headers.html	Edgar Link	pending
0001360604-17-000035-index.html	Edgar Link	pending
0001360604-17-000035.txt	Edgar Link	pending
0001360604-17-000035-xbrl.zip	Edgar Link	pending
a2017331ex311.htm	Edgar Link	pending
a2017331ex312.htm	Edgar Link	pending
a2017331ex313.htm	Edgar Link	pending
a2017331ex314.htm	Edgar Link	pending
a2017331ex321.htm	Edgar Link	pending
a2017331ex322.htm	Edgar Link	pending
a2017331ex323.htm	Edgar Link	pending
a2017331ex324.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
hta-20170331.xml	Edgar Link	completed
hta-20170331.xsd	Edgar Link	pending
hta-20170331_cal.xml	Edgar Link	unprocessable
hta-20170331_def.xml	Edgar Link	unprocessable
hta-20170331_lab.xml	Edgar Link	unprocessable
hta-20170331_pre.xml	Edgar Link	unprocessable
hta201733110-q.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$HR
Healthcare Realty Trust Inc Stock $hr

2017 Q1 Form 10-Q Financial Statement

#000136060417000035 Filed on April 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR Healthcare Realty Trust Inc Stock $hr

2017 Q1 Form 10-Q Financial Statement

#000136060417000035 Filed on April 27, 2017

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$HR
Healthcare Realty Trust Inc Stock $hr